2018-11-16T09:44:21Z
2018-11-16T09:44:21Z
2015-01-08
2018-07-24T12:35:07Z
Marginal zone lymphoma (MZL) is the third most common subtype of B-cell non-Hodgkin lymphoma. Here we perform a two-stage GWAS of 1,281 MZL cases and 7,127 controls of European ancestry and identify two independent loci near BTNL2 (rs9461741, P - 3.95 x 10(-15)) and HLA-B (rs2922994, P - 2.43 x 10(-9)) in the HLA region significantly associated with MZL risk. This is the first evidence that genetic variation in the major histocompatibility complex influences MZL susceptibility.
Article
Published version
English
Malaltia de Hodgkin; Cèl·lules B; Hodgkin's disease; B cells
Nature Publishing Group
Reproducció del document publicat a: https://doi.org/10.1038/ncomms6751
Nature Communications, 2015, vol. 6
https://doi.org/10.1038/ncomms6751
cc by (c) Vijai et al., 2015
http://creativecommons.org/licenses/by/3.0/es/